Cargando…
Effect of Sulodexide on Circulating Blood Cells in Patients with Mild COVID-19
Background. Despite the fact that COVID-19 usually manifests with severe pneumonia, there is a growing body of evidence that life-threatening multiorgan damage is caused by vascular and hemostatic abnormalities. Since there is no established therapy, assessing antithrombotics is indeed important. Su...
Autores principales: | Melkumyants, Arthur, Buryachkovskaya, Lyudmila, Lomakin, Nikita, Antonova, Olga, Docenko, Julia, Ermishkin, Vladimir, Serebruany, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999543/ https://www.ncbi.nlm.nih.gov/pubmed/35407602 http://dx.doi.org/10.3390/jcm11071995 |
Ejemplares similares
-
Cost-effectiveness of Platelet Function-Guided Strategy with Clopidogrel or Ticagrelor
por: Lomakin, Nikita, et al.
Publicado: (2019) -
Sulodexide in the Treatment of Early Stages of COVID-19
por: Gonzalez-Ochoa, Alejandro, et al.
Publicado: (2021) -
The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016) -
Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies
por: Olde Engberink, Rik H. G., et al.
Publicado: (2016) -
Sulodexide in IgA nephropathy
Publicado: (2013)